Literature DB >> 1417284

Benefits of combined balloon pumping and percutaneous cardiopulmonary bypass.

S J Phillips1, R H Zeff, C Kongtahworn, A Grignon, L Barker, L A Iannone, M Tannenbaum, M H Verhey, W J Wickemeyer, M G Ghali.   

Abstract

Sixteen patients (2 women, 14 men) aged 29 to 72 years with continued cardiogenic shock during intraaortic balloon pumping (IABP) had additional treatment with percutaneous cardiopulmonary bypass (PBY). Cause of cardiogenic shock was myocardial infarction in 7 (3 survived), failed percutaneous transluminal coronary angioplasty requiring emergency coronary artery bypass grafting in 5, postoperative aortic valve replacement in 1, postoperative emergency coronary artery bypass grafting in 1, after cardiac transplantation in 1, and bridging to transplantation in 1. Mean blood pressure with PBY and IABP combined was 75 mm Hg versus 60 mm Hg with IABP off. Percutaneous cardiopulmonary bypass flows ranged from 0.8 to 2.1 L/min with a mean flow of 1.3 L/min. Time on IABP ranged from 24 hours to 1 week. Time on IABP to PBY ranged from 1 to 20 hours, and time on PBY ranged from 65 minutes to 20 hours. Ten of 16 (63%) were successfully weaned, and 3 died after weaning. Seven of 16 (44%) survive. Combined IABP with PBY appears to be a better therapy than either one individually. Staging the therapy as the balloon first in and last out appears to be a good methodology.

Entities:  

Mesh:

Year:  1992        PMID: 1417284     DOI: 10.1016/0003-4975(92)90647-m

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  1 in total

1.  Clinical impact of intra-aortic balloon pump during extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock.

Authors:  Taek Kyu Park; Jeong Hoon Yang; Seung-Hyuk Choi; Young Bin Song; Joo-Yong Hahn; Jin-Ho Choi; Kiick Sung; Young Tak Lee; Hyeon-Cheol Gwon
Journal:  BMC Anesthesiol       Date:  2014-04-14       Impact factor: 2.217

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.